ways to connect

News

09 February 2013
Clinical trials are underway for SonarMed's innovative neonatal airway monitoring device.

Events

 
 
 

about SonarMed®

SonarMed® was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal tubes (also known as ETTs or artificial airways) that are used in patients who cannot breathe on their own.
 
The technology was initially developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka, using the principles of acoustic reflectometry to provide the medical community with a more comprehensive approach to assist in the management of endotracheal tubes.
 
The company’s first product – the SonarMed® AirWave™– is a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The AirWave™ may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care.
 
Development of the SonarMed® AirWave™ was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Indiana 21st Century Research and Technology Fund.

 

 

leadership

David Wortman, Chairman
Dave is an experienced technology executive/entrepreneur. He was a cofounder of Pritsker and the former CEO of Made2Manage (NASDAQ: MTMS) and Mezzia. He is currently a Venture Partner with Spring Mill Venture Partners and is a Managing Director of Midwest Venture Partners.

Tom Bumgardner, President & CEO
Tom is an experienced senior executive/entrepreneur with successful experience in start-ups to Fortune 20 companies. He has managed P&Ls and budgets of $25MM to $500MM in high growth and turnaround environments. Tom lettered in varsity football while earning his bachelor's degree in mechanical engineering atTexas A&M University and later earned a master's in business administration at University of Texas. Tom also sits on the Biomedical Engineering Industry Advisory Board at Texas A&M University.

David Gunn, VP Strategy and Business Development
David is a successful entrepreneur and corporate sales and marketing professional; product launch, channel strategy, vendor and distribution management, sales operations and marketing. David earned his bachelor's degree in business administration at SMU and his master's degree in business administration at Cornell University.

Laura Lyons, VP Clinical/Quality/Regulatory Affairs
Laura is the clinician of the group having spent much of her early career as a Respiratory Therapist in various clinical settings. She has a strong background in all aspects of regulatory, quality, and FDA relations with companies such as AVL and Roche. She has consulted widely in the regulatory affairs area for top medical device and diagnostic companies. Laura also has a bachelor's degree in business administration.

Andrew Hansen, MD, Medical Director
Dr. Hansen is a accomplished cardiovascular surgeon including over 4,000 thoracic surgeries.  He is a Fellow, Michael E. DeBakey Institute for Comparative Cardiovascular Science and Biomedical Devices, He has served as medical director of Salient Pharmaceuticals, earned his BS at Texas A&M, MD at Texas Tech and completed his surgical residencies at Baylor and Emory.  Andy also earned a masters in business administration at Texas A&M.
 
Jeff Mansfield, PhD, Founder and VP of Research and Development
Jeff possesses deep expertise in biomedical acoustics. He has over 15 years of experience in medical device R&D, and was formerly a Senior Research Scientist and Systems Engineer at Cardiac Science. He received his bachelor's degree in electrical engineering at Drexel University and his master's degree and doctorate in electrical and computer engineering at Purdue University.

Mark Jefferson, Sales and Marketing Advisor
Mark has a stellar 25-year track record of success selling and marketing medical devices and disposable medical products.  As VP of Sales and Marketing he led Vital Signs from less than $10MM in sales to over $250MM in sales. Vital Signs later sold to GE Medical for ~$1B. Mark provides tremendous support to the SonarMed team, offering practical, concrete advice for best practices in medical device sales and marketing.

Zahir Lavji, Strategy and Marketing Advisor
Zahir is a seasoned Fortune 75 Sr. Strategy and Marketing executive with over 25 years of experience at Abbott Labs as VP of Pharmaceuticals International Marketing, and VP Global Commercial Operations for Abbot Diabetes Care. Zahir brings a wealth of international experience to the team heading up our efforts to set up SonarMed’s global sales and distribution and offering additional guidance on strategy and marketing.



Sven Schreiber, Director of Operations
Sven's experience includes management roles in manufacturing and quality assurance as well as roles in systems and manufacturing process engineering at 3M and Aventis Pharmaceuticals. He is a certified Six Sigma Greenbelt with experience in Lean Manufacturing techniques and received his bachelor's degree in mechanical engineering at Purdue University. 

David Pittman, Regional Sales Manager
David has over 20 years of successful Sales and Marketing experience in medical device, pharmaceutical, health insurance, and manufacturing.  He specializes in new business development, product launch, and territory expansion.  He earned his bachelor's degree in journalism at the University of South Carolina.
 

 

news

For the recent news, please visit our news page.
 

 

events

For upcoming events, please visit our events page.